CardiovascularVAGINALGeneric
NYSERT
NYSTATIN
Standard Dose
100,000 UNITS
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview NYSERT is listed in Drugs@FDA under application 050478 (NDA).
Marketing status: Discontinued Active ingredient NYSTATIN Form and strength SUPPOSITORY;VAGINAL - 100,000 UNITS Sponsor WARNER CHILCOTT Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview NYSERT is listed in Drugs@FDA under application 050478 (NDA). Marketing status: Discontinued Active ingredient NYSTATIN Form and strength SUPPOSITORY;VAGINAL - 100,000 UNITS Sponsor WARNER CHILCOTT Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.